GB201817676D0 - T cell antigen receptor chimera - Google Patents
T cell antigen receptor chimeraInfo
- Publication number
- GB201817676D0 GB201817676D0 GBGB1817676.8A GB201817676A GB201817676D0 GB 201817676 D0 GB201817676 D0 GB 201817676D0 GB 201817676 A GB201817676 A GB 201817676A GB 201817676 D0 GB201817676 D0 GB 201817676D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antigen receptor
- cell antigen
- receptor chimera
- chimera
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 title 1
- 108010092262 T-Cell Antigen Receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4647—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4648—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1817676.8A GB2569692A (en) | 2018-10-30 | 2018-10-30 | T cell antigen receptor chimera |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1817676.8A GB2569692A (en) | 2018-10-30 | 2018-10-30 | T cell antigen receptor chimera |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201817676D0 true GB201817676D0 (en) | 2018-12-19 |
GB2569692A GB2569692A (en) | 2019-06-26 |
Family
ID=64655687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1817676.8A Withdrawn GB2569692A (en) | 2018-10-30 | 2018-10-30 | T cell antigen receptor chimera |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2569692A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017197347A1 (en) * | 2016-05-12 | 2017-11-16 | Adicet Bio, Inc. | METHODS FOR SELECTIVE EXPANSION OF γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF |
AU2018236461A1 (en) * | 2017-03-17 | 2019-09-19 | Fred Hutchinson Cancer Center | Immunomodulatory fusion proteins and uses thereof |
-
2018
- 2018-10-30 GB GB1817676.8A patent/GB2569692A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2569692A (en) | 2019-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272302A (en) | Chimeric antigen receptor mediated cell targeting | |
EP3440191A4 (en) | Chimeric antigen receptor t cell compositions | |
IL280718A (en) | T cell receptor constructs and uses thereof | |
IL254254B (en) | Chimeric antigen receptor | |
GB201503742D0 (en) | Chimeric antigen receptor | |
GB201607968D0 (en) | Chimeric antigen receptor | |
IL281232A (en) | Chimeric antigen receptor for solid cancer and t cells expressing chimeric antigen receptor | |
GB201610512D0 (en) | Chimeric antigen receptor | |
ZA202005837B (en) | Cd83-binding chimeric antigen receptors | |
ZA201906321B (en) | Chimeric antigen receptor | |
SG11202101169PA (en) | Chimeric antigen receptor that binds hla-dr and car-t cell | |
GB201807870D0 (en) | A CD79-specific chimeric antigen receptor | |
IL281428A (en) | Chimeric antigen receptor | |
IL285587A (en) | Hypoxia-responsive chimeric antigen receptors | |
IL285909A (en) | Anti-bcma chimeric antigen receptors | |
IL277946A (en) | Chimeric antigen receptor specific for interleukin-23 receptor | |
GB201801831D0 (en) | Chimeric receptor | |
SG11202001011XA (en) | Chimeric antigen receptor and car-t cells that bind cxcr5 | |
GB201709508D0 (en) | Chimeric antigen receptor | |
GB201807862D0 (en) | Chimeric antigen receptor | |
IL278992A (en) | Chimeric antigen receptor t cell therapy | |
GB201519900D0 (en) | Chimeric antigen receptor | |
GB201817676D0 (en) | T cell antigen receptor chimera | |
GB201721831D0 (en) | T cell antigen receptor chimera | |
GB201815775D0 (en) | Chimeric antigen receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |